National
Anti-gay Bush official sentenced to jail
Bloch guilty in criminal contempt of Congress case
Bloch
A Bush administration official who came under criticism for refusing to enforce anti-discrimination policies protecting gay federal workers was sentenced on March 30 to one month in jail on a charge of criminal contempt of Congress.
Scott J. Bloch, who served as head of the U.S. Office of Special Council from 2004 to 2008, is appealing the sentence, which was handed down in Washington by U.S. District Court Magistrate Judge Deborah Robinson. Robinson also sentenced him to one year of unsupervised probation and 200 hours of community service.
She agreed to put a stay on the sentence while Bloch’s attorney, William Sullivan, files an appeal with the U.S. Court of Appeals for the District of Columbia. Sullivan said the appeal is based on Bloch’s contention that he did not know the offense of contempt of Congress, to which he pleaded guilty in April 2010, carries a required minimum sentence of 30 days in jail.
The appeal seeks to overturn Robinson’s denial last month of a motion by Bloch to withdraw his guilty plea.
Robinson said she interpreted the statute to include a required jail term of at least one month for those convicted of or who plead guilty to criminal contempt of Congress. She noted that at the time Bloch pleaded guilty, he explicitly acknowledged — in response to her questions in the courtroom — that a prosecutors’ plea bargain agreement he accepted did not prevent her from sentencing him to a prison term of up to six months.
Sullivan strongly disputes her interpretation of the statute, saying in court papers that two other judges have sentenced people convicted under the contempt of Congress statute to probation without any jail time. Robinson said those cases were irrelevant because the statute gives her discretion to sentence Bloch to up to six months in jail.
Bloch’s sentencing last week marked yet another twist in a seven-year saga that began in 2004, upon his appointment by President George W. Bush as head of an office charged with protecting federal employees from discriminatory personnel practices. The independent Office of Special Counsel, which Bloch headed, is also charged with protecting federal employees who become whistleblowers by disclosing corruption or gross incompetence within federal government agencies.
Immediately upon taking office, Bloch announced that he disagreed with a longstanding interpretation of a U.S. civil service law believed to protect federal workers from job-related discrimination based solely on their sexual orientation. Saying he interpreted the statute to limit its coverage of gays to matters involving “homosexual acts,” Bloch said gay or lesbian federal employees could no longer be protected against improper personnel practices based on their sexual orientation.
His position on gay federal workers triggered an immediate outcry from LGBT advocacy organizations and their allies in Congress. A spokesperson for Bush surprised some political observers when he said it remained the policy of the White House and the administration that gay or lesbian federal workers were, in fact, protected against sexual orientation discrimination.
LGBT rights groups, while expressing appreciation for the Bush administration statement, pointed out that Bloch appeared to be ignoring the statement by continuing to operate the Office of Special Counsel as if gay and lesbian federal employees were not protected.
In addition to criticism over his position on gay federal workers, Block came under attack over allegations that he improperly sought to purge employees in his office who disagreed with him, including at least two gay employees. The latter allegations led to a congressional investigation into Bloch and the Office of Special Counsel.
Allegations that eventually led to his being charged with contempt of Congress began in 2006, when investigators raised questions about whether Bloch arranged for a computer services company called Geeks on Call to “scrub” files from his office computer as well as from the computers of two of his political appointees at the Office of Special Counsel.
Bloch was under investigation at the time by the inspector general of the U.S. Office of Personnel Management that he allegedly improperly retaliated against former Office of Special Counsel employees.
In May 2008, the FBI raided Bloch’s office and home, confiscating computers and various files. In October 2008 the White House requested and received his resignation.
The case docket for the U.S. District Court, which is now handling Bloch’s criminal case, shows that his sentencing date was postponed several times since he pleaded guilty nearly a year ago. The main cause of the postponements has been his attorney’s dispute with the judge over whether the contempt of Congress statute carries a mandatory jail term of at least 30 days.
In an unusual development, federal prosecutors joined defense attorney Sullivan in arguing in court filings that they did not agree with Robinson’s interpretation that the statute carries a required jail term. Assistant U.S. Attorney Glenn Leon, the lead prosecutor in the case, argued in court papers that the government believes the statute gives judges discretion to sentence someone to probation without a prison term.
“Both parties entered into the plea agreement believing that 2 U.S.C. 192 [the contempt of Congress statute] was a probation-eligible offense,” Leon said in a court brief. “In light of the Court’s ruling to the contrary, the government believes that fairness requires it to not oppose the defendant’s motion to withdraw, because otherwise the plea agreement would not reflect what the parties negotiated and agreed to in good faith.”
Some critics, including gay blogger John Aravosis of AmericaBlog, questioned whether the Obama administration was siding with Bloch to prevent a legal precedent that could result in the jailing of Obama administration officials who might get into trouble with the law in the future.
During a court hearing last week, Robinson agreed to consider another request by Sullivan that she allow Bloch to serve his one-month jail sentence in home confinement if the sentence is upheld on appeal.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
